跳至主要内容
临床试验/EUCTR2017-005110-58-NL
EUCTR2017-005110-58-NL进行中(未招募)1 期

Efficacy of a predefined vitamin D dosing regimen in vitamin D-insufficient multiple myeloma patients. - Efficacy of vitamin D supplementation in multiple myeloma patients.

Medical Centre Leeuwarden0 个研究点目标入组 40 人开始时间: 2018年5月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subjects are (newly) diagnosed with smoldering or symptomatic multiple myeloma. Subjects must be over 18 years of age. Subjects must be able to give informed consent. Subjects with a 25-hydroxyvitamin D level =75 nmol/l.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 11
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 29

排除标准

  • Contraindications for the use of vitamin D: Hypersensitivity to the active substance(s) or to any of the excipients; Hypercalcaemia and/or hypercalciuria; Nephrolithiasis and/or nephrocalcinosis; Serious renal impairment; Hypervitaminosis D; Pseudohypoparathyroidism.
  • The use of vitamin D tablets or multivitamin tablets containing vitamin D

研究者

发起方
Medical Centre Leeuwarden

相似试验